Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN-  in Lupus Patients In Vivo

(2014) S. N. Kariuki et al.   JOURNAL OF IMMUNOLOGY

Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-β/α ratios in rheumatoid arthritis patients: A post hoc analysis of a predominantly Hispanic cohort

(2010) Clio P. Mavragani et al.   ARTHRITIS AND RHEUMATISM

Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis

(2010) Lisa G. M. van Baarsen et al.   ARTHRITIS AND RHEUMATISM

Recent advances in the genetics of rheumatoid arthritis

(2010) Soumya Raychaudhuri   CURRENT OPINION IN RHEUMATOLOGY

B Cell-Targeted Therapies for Systemic Lupus Erythematosus

(2010) R. John Looney   DRUGS

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

(2010) Eli A Stahl et al.   NATURE GENETICS

Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers

(2010) Thomas Dörner et al.   PHARMACOLOGY & THERAPEUTICS

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

(2010) Lisa GM van Baarsen et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies

(2009) Y K O Teng et al.   ANNALS OF THE RHEUMATIC DISEASES

Interferon   for rheumatoid arthritis: new clothes for an old kid on the block

(2009) M. J Vervoordeldonk et al.   ANNALS OF THE RHEUMATIC DISEASES

Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis

(2009) Hatice Bilgic et al.   ARTHRITIS AND RHEUMATISM

Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases - lessons from B cell-depletion therapy

(2009) M. J. Leandro et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Type I IFNs and their role in the development of autoimmune diseases

(2009) Laura M Burdick et al.   Expert Opinion On Drug Safety

Peripheral blood gene expression profiling in Sjögren's syndrome

(2009) E S Emamian et al.   GENES AND IMMUNITY

Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers

(2009) C L Bos et al.   GENES AND IMMUNITY

Age- and gender-specific modulation of serum osteopontin and interferon-α by osteopontin genotype in systemic lupus erythematosus

(2009) S N Kariuki et al.   GENES AND IMMUNITY

Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis

(2009) Tineke Cantaert et al.   RHEUMATOLOGY

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis

(2009) Maria Rehnberg et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab treatment in rheumatoid arthritis: how does it work?

(2009) Maria JH Boumans et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

(2009) Magda Nakou et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab-Induced Changes in Hematolymphoid Tissues Found at Autopsy

(2008) Adina M. Cioc et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

(2008) Shouvik Dass et al.   ARTHRITIS AND RHEUMATISM

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients

(2008) Lisa G. M. van Baarsen et al.   PLoS One

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor   expression in the synovium

(2007) C A Wijbrandts et al.   ANNALS OF THE RHEUMATIC DISEASES